Erik Halstrom, MBA
Turning Point Rx
Turning Point is an innovative new specialty pharmacy distribution model comprised of top performing, carefully vetted specialty pharmacies. We work with leading drug manufacturers and payers to promote access to today’s most powerful therapies while providing high-touch service and support to patients.
Prior to joining Turning Point, Erik led the Specialty Division of a diversified healthcare and technology company. Prior to his last engagement, Erik was the vice president of corporate business development for FFF Enterprises a diversified healthcare company. Erik started his career in the pharmaceutical industry where he held leadership roles with Eli Lilly and Merck in the areas of sales, in-line and new product marketing, market access, PBM and Managed Care corporate accounts, strategic planning, and the creation of new distribution models.
Erik holds a Bachelor of Science in Business Management from St. John’s University in Minnesota, and a Masters in Business Administration from St. Joseph’s University in Philadelphia.